These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12827283)

  • 1. Low-density lipoprotein and its effect on human blood platelets.
    Relou IA; Hackeng CM; Akkerman JW; Malle E
    Cell Mol Life Sci; 2003 May; 60(5):961-71. PubMed ID: 12827283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular requirements in the recognition of low-density lipoproteins (LDL) by specific platelet membrane receptors.
    Pedreño J; Sánchez-Quesada JL; Cabré A; Masana L
    Thromb Res; 2000 Jul; 99(1):51-60. PubMed ID: 10904103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy.
    Aviram M; Hussein O; Rosenblat M; Schlezinger S; Hayek T; Keidar S
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):39-45. PubMed ID: 9456275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet interaction with high and low density lipoproteins.
    Aviram M; Brook JG
    Atherosclerosis; 1983 Mar; 46(3):259-68. PubMed ID: 6847742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
    Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H
    Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-protein particles secreted from activated platelets reduce macrophage uptake of low density lipoprotein.
    Fuhrman B; Brook GJ; Aviram M
    Atherosclerosis; 1991 Aug; 89(2-3):163-73. PubMed ID: 1793444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro.
    Yang SH; Li YT; Du DY
    Thromb Res; 2013; 132(6):702-11. PubMed ID: 24144446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Scavenger Receptor CD68 Regulates Platelet Mediated Oxidized Low-Density Lipoprotein (oxLDL) Deposition in Atherosclerotic Vessels at an Early Stage of Atherosclerosis in LDLR
    Zeibig S; Büttcher M; Goebel S; Pauli J; Hunger A; Ungerer M; Gawaz M; Münch G
    Cell Physiol Biochem; 2019; 52(4):681-695. PubMed ID: 30921507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets as an inter-player between hyperlipidaemia and atherosclerosis.
    Li N
    J Intern Med; 2024 Jul; 296(1):39-52. PubMed ID: 38704820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein.
    Siess W
    Pathophysiol Haemost Thromb; 2006; 35(3-4):292-304. PubMed ID: 16877878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonate transfer between platelets and lipoproteins.
    Surya II; Gorter G; Akkerman JW
    Thromb Haemost; 1992 Dec; 68(6):719-26. PubMed ID: 1287888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic susceptibility of platelet low density lipoprotein receptor.
    Pedreño J; Fernández R
    Lipids; 1995 Oct; 30(10):927-33. PubMed ID: 8538380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein enhances platelet secretion via integrin-alphaIIbbeta3-mediated signaling.
    Hackeng CM; Huigsloot M; Pladet MW; Nieuwenhuis HK; van Rijn HJ; Akkerman JW
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):239-47. PubMed ID: 9974403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis.
    Siegel-Axel D; Daub K; Seizer P; Lindemann S; Gawaz M
    Cardiovasc Res; 2008 Apr; 78(1):8-17. PubMed ID: 18218686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation.
    Aviram M
    Thromb Haemost; 1995 Jul; 74(1):560-4. PubMed ID: 8578524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet signaling induced by lipoproteins.
    Korporaal SJ; Akkerman JW
    Cardiovasc Hematol Agents Med Chem; 2006 Apr; 4(2):93-109. PubMed ID: 16611046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia.
    Nofer JR; Tepel M; Kehrel B; Wierwille S; Walter M; Seedorf U; Zidek W; Assmann G
    Circulation; 1997 Mar; 95(6):1370-7. PubMed ID: 9118502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of plasma lipoproteins with human platelets.
    Curtiss LK; Plow EF
    Blood; 1984 Aug; 64(2):365-74. PubMed ID: 6331546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets.
    Engelmann B; Kögl C; Kulschar R; Schaipp B
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):781-9. PubMed ID: 8645158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.